PALMIERI, SERENA
PALMIERI, SERENA
Dipartimento di Scienze Cliniche e di Comunità
Germline targeted next-generation sequencing in patients with adrenal incidentalomas
2025 E. Messina, A. Inglesi, S. Puglisi, A. Barač Nekić, V. Morelli, Y. Alessi, K. Zibar Tomsic, S. Palmieri, P. Tomaiuolo, E. Grosso, F. Ferraù, I. Chiodini, D. Kastelan, A. Pia, M. Scatolini, G. Reimondo, M. Terzolo
Therapeutic potential of targeting the FLNA‐regulated Wee1 kinase in adrenocortical carcinomas
2025 E. Esposito, G. Marra, R. Catalano, S. Maioli, E. Nozza, A.M. Barbieri, C. Hantel, G. Di Dalmazi, S. Sigala, J. Geginat, E. Cassinotti, L. Baldari, S. Palmieri, A. Mangone, A. Berruti, E. Ferrante, G. Mantovani, E. Peverelli
Emerging role of IGF1R and IR expression and localisation in adrenocortical carcinomas
2025 R. Catalano, E. Nozza, B. Altieri, E. Esposito, G.A. Croci, A.M. Barbieri, D. Treppiedi, S. Di Bari, O. Kimpel, M. Detomas, M. Tamburello, M.P. Schauer, S. Herterich, A. Angelousi, M. Luconi, L. Canu, G. Nesi, C. Hantel, S. Sigala, L. Landwehr, G. Di Dalmazi, E. Cassinotti, L. Baldari, S. Palmieri, A. Mangone, E. Ferrante, C.L. Ronchi, G. Mantovani, E. Peverelli
Adrenalectomy reduces the risk of vertebral fractures in patients with mild autonomous cortisol secretion
2025 V. Morelli, V. Favero, S. Frigerio, C. Aresta, F. Pugliese, A.S. Salcuni, A. Risio, C. Eller-Vainicher, S. Palmieri, E. Cairoli, S. Corbetta, G. Mantovani, A. Scillitani, I. Chiodini
Preclinical evaluation of the antitumoral efficacy of Wee1 inhibitor AZD1775 in adrenocortical carcinoma
2025 E. Nozza, E. Emanuela, G. Di Muro, S. Di Bari, R. Catalano, G. Lopez, V. Vaira, A.M. Barbieri, G. Marra, M. Federica, T. Donatella, M. Battistin, Di Dalmazi Guido, S. Palmieri, F. Emanuele, G. Mantovani, E.M. Peverelli
Are comorbidities of patients with adrenal incidentaloma tied to sex?
2024 S. Puglisi, A. Barač Nekić, V. Morelli, Y. Alessi, M. Fosci, A. Pani, K. Zibar Tomsic, S. Palmieri, F. Ferraù, A. Pia, I. Chiodini, D. Kastelan, G. Reimondo, M. Terzolo
Sphingosine kinase 1 inhibitor safingol as a new possible therapeutic strategy for adrenocortical carcinoma
2024 E. Nozza, R. Catalano, E. Esposito, S. Palmieri, B. Altieri, L. Landwehr, H. Constanze, S. Sigala, E. Ferrante, G. Mantovani, E. Peverelli
Therapeutic potential of targeting the FLNA-regulated Wee1 kinase in adrenocortical carcinomas
2024 E. Esposito/, R. Catalano, E. Nozza, G. Marra, S. Maioli, G. Dimuro, A.M. Barbieri, H. Constanze, G. Didalmazi, J.E. Geginat, E. Cassinotti, L. Baldari, S. Palmieri, A. Mangone, E. Ferrante, G. Mantovani, E. Peverelli
IGF2R: a new player in the insulin-like growth factor 2 (IGF2) pathway sustaining adrenocortical carcinoma cells growth
2023 E. Nozza, R. Catalano, E. Esposito, A.M. Barbieri, G. Marra, D. Treppiedi, G. Di Muro, F. Mangili, H. Constanze, S. Sigala, S. Palmieri, S. Frigerio, E. Ferrante, M. Arosio, G. Mantovani, E. Peverelli
Prevalence and clinical features of armadillo repeat-containing 5 mutations carriers in a single center cohort of patients with bilateral adrenal incidentalomas
2023 V. Morelli, F.M. Elli, S. Frigerio, W. Vena, S. Palmieri, C. Lucca, M.A. Maffini, A. Contarino, F. Bagnaresi, G. Mantovani, M. Arosio
Bisphosphonates after Denosumab withdrawal reduce the vertebral fractures incidence
2021 G. Grassi, I. Chiodini, S. Palmieri, E. Cairoli, M. Arosio, C. Eller-Vainicher
IMPACT OF CHOLECALCIFEROL SUPPLEMENTATION ON SKELETAL AND NON-SKELETAL MANIFESTATIONS IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM SUBMITTED TO PARATHYROIDECTOMY OR FOLLOWED UP WITHOUT SURGERY: CARDIOVASCULAR OUTCOMES
2021 S. Palmieri
Denosumab or oral bisphosphonates in primary osteoporosis: a “real-life” study
2018 E. Cairoli, S. Palmieri, G. Goggi, L. Roggero, M. Arosio, I. Chiodini, C. Eller-Vainicher
HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy
2018 G. Marcucci, L. Cianferotti, S. Parri, P. Altieri, E. Arvat, S. Benvenga, C. Betterle, M. Bondanelli, M. Boscaro, V. Camozzi, G.M. Centaro, F. Cetani, I. Chiodini, A. Ciampolillo, A. Colao, S. Corbetta, M.L. De Feo, E.D. Uberti, A. Faggiano, R. Fornari, A.L. Gaspari, F. Giorgino, V. Giuliani, M. Iacobone, N. Innaro, O. Lamacchia, A. Lenzi, G. Mantovani, C. Marcocci, L. Masi, S. Migliaccio, S. Palmieri, R. Pasquali, G. Perigli, V. Piccini, E. Romagnoli, R.M. Ruggeri, F. Rulli, M.T. Samà, G. Tomaino, F. Trimarchi, M.C. Zatelli, M.L. Brandi
Protective Effect of Denosumab on Bone in Older Women with Primary Hyperparathyroidism
2018 C. Eller-Vainicher, S. Palmieri, E. Cairoli, G. Goggi, A. Scillitani, M. Arosio, A. Falchetti, I. Chiodini
Non classical complications of primary hyperparathyroidism
2018 I. Chiodini, E. Cairoli, S. Palmieri, J. Pepe, M.D. Walker
Adrenal Function and Skeletal Regulation
2018 I. Chiodini, C. Battista, E. Cairoli, C. Eller-Vainicher, V. Morelli, S. Palmieri, A.S. Salcuni, A. Scillitani
Clinical presentation and management of patients with primary hyperparathyroidism in Italy
2018 F. Saponaro, F. Cetani, A. Repaci, U. Pagotto, C. Cipriani, J. Pepe, S. Minisola, C. Cipri, F. Vescini, A. Scillitani, A. Salcuni, S. Palmieri, C. Eller-Vainicher, I. Chiodini, B. Madeo, E. Kara, E. Castellano, G. Borretta, L. Gianotti, F. Romanelli, V. Camozzi, A. Faggiano, S. Corbetta, L. Cianferotti, M.L. Brandi, M.L. de Feo, A. Palermo, G. Vezzoli, F. Maino, M. Scalese, C. Marcocci
Bone involvement and mineral metabolism in Williams’ syndrome
2018 S. Palmieri, M.F. Bedeschi, E. Cairoli, V. Morelli, M.E. Lunati, A. Scillitani, V. Carnevale, F. Lalatta, A.M. Barbieri, E. Orsi, A. Spada, I. Chiodini, C. Eller-Vainicher
Cardiovascular events in patients with mild autonomous cortisol secretion : analysis with artificial neural networks.
2017 V. Morelli, S. Palmieri, A. Lania, A.S. Tresoldi, S.L. Corbetta, E. Cairoli, C. Eller Vainicher, M. Arosio, M. Copetti, E. Grossi, I. Chiodini